🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of the VIP-A study is to determine the effect of apremilast on ...
Status
Completed
Location
University of Southern California
Start Date
2017-04-24
Trial ID
NCT03082729
Treatments Being Tested
The purpose of this study is to determine whether apremilast is safe and ef...
Status
Completed
Location
Arizona Research Center
Start Date
2010-12-09
Trial ID
NCT01307423
Treatments Being Tested
The primary objective of this study is to evaluate the time to confirmed cl...
Status
Completed
Location
Pinnacle Research Group LLC
Start Date
2020-11-24
Trial ID
NCT04590586
The study will include a representative sample of 150 patients with active ...
Status
Completed
Location
ASZ Aalst
Start Date
2017-04-21
Trial ID
NCT03096990
Treatments Being Tested
The primary objective of this post-marketing study is to assess the safety ...
Status
Completed
Location
University of Alabama at Birmingham
Start Date
2023-10-24
Trial ID
NCT06088199
Treatments Being Tested
Sixteen week open label study of apremilast in combination with topical ste...
Status
Completed
Location
DermResearch, PLLC
Start Date
2016-12-29
Trial ID
NCT03000309
Treatments Being Tested
The objective of this NIS is the collection of data on the utilization of A...
Status
Completed
Location
Gertraud Krähn-Senftleben
Start Date
2015-08-03
Trial ID
NCT02626793
Vulvodynia is characterized by persistent vulvar pain, which often occurs u...
Status
Completed
Location
William Beaumont Hospital
Start Date
2008-12
Trial ID
NCT00814632
Treatments Being Tested
This study is designed to assess the efficacy of apremilast, either in mono...
Status
Completed
Location
The Doctors of Saint John's Medical Group
Start Date
2019-02-06
Trial ID
NCT03783026
Treatments Being Tested
Most people with psoriasis have very limited disease, yet that disease may ...
Status
Withdrawn
Location
Wake Forest University Health Sciences
Start Date
2025-06
Trial ID
NCT05601492